Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
The gene p53 encodes a transcriptional activator of genes involved in growth arrest, DNA repair and apoptosis. Loss of p53 function contributes to tumour development in vivo. The transcriptional activation function of p53 is inactivated by interaction with the mdm2 gene product. Amplification of mdm2 has been observed in 36% of human sarcomas, indicating that it may represent an alternative mechanism of preventing p53 function in tumour development. To study mdm2 function in vivo, we generated an mdm2 null allele by homologous recombination. Mdm2 null mice are not viable, and further analysis revealed embryonic lethality around implantation. To examine the importance of the interaction of MDM2 with p53 in vivo, we crossed mice heterozygous for mdm2 and p53 and obtained progeny homozygous for both p53 and mdm2 null alleles. Rescue of the mdm2-/- lethality in a p53 null background suggests that a critical in vivo function of MDM2 is the negative regulation of p53 activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mdm2 can recruit HDAC1 to p53 to remove these acetylation marks and allow for p53 ubiquitination and degradation [49] in in vitro and mouse models [47,50].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [50]
In the citing paper
“Loss of Mdm2 leads to cell death by apoptosis and embryonic lethality at the blastocyst stage, and this phenotype is completely rescued by concomitant deletion of p53 (Chavez-Reyes, et al., 2003; Jones, et al., 1995; Montes de Oca Luna, et al., 1995).”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Montes de Oca Luna, et al., 1995
In the citing paper
“Mouse genetic models strongly suggest that MDM2 and MDMX are the two major p53 antagonists in vivo107,108”
From MDM2, MDMX and p53 in oncogenesis and cancer therapy (2013) · cites this paper as [107]
In the citing paper
“Mouse genetic models strongly suggest that MDM2 and MDMX are the two major p53 antagonists in vivo107,108 and that they exert non-overlapping inhibitory activities towards p53 (Refs 24,109).”
From MDM2, MDMX and p53 in oncogenesis and cancer therapy (2013) · cites this paper as [107]
In the citing paper
“The crucial importance of MDM2 in regulating p53 was demonstrated using Mdm2-null mice, which display very early embryonic lethality (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
From p53 at a glance (2010) · cites this paper as Montes de Oca Luna et al., 1995
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Research works printed but not linked: 1
- Greenblatt, M. S., Bennett, W. P., Hollstein, M. & Harris C. C. Cancer Res. 54, 4855–4878 (1994).
Cited by
Items 301–400 of 1,001
Thomasová, D., Mulay, S. R., Bruns, H., & Anders, H. (2012) · Neoplasia · doi:10.1593/neo.121534 · Cited by 138
“This phenotype can be entirely rescued by concomitant deletion of p53 [10].”
BackgroundMDM2 and MDMX: Alone and together in regulation of p53.
Shadfan, M., Lopez-Pajares, V., & Yuan, Z.-M. (2012) · PubMed · Cited by 179
Akt: a key transducer in cancer
Tsai, P., Lai, Y., Manne, R., Tsai, Y.-S., Sarbassov, D. D., & Lin, H. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00860-9 · Cited by 143
Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122
Apoptosis at the time of embryo implantation in mouse and rat
Pampfer, S., & Donnay, I. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400516 · Cited by 140
“Conversely, mouse embryos lacking the mouse-double-minute-2 (MDM2) gene whose protein is a negative regulator of p53(81) were found to die shortly after implantation.(82,83) Abnormally low numbers of cells were detected in the ectoderm layer of MDM2 egg cylinder embryos, probably because the lack of p53 down-regulatio…”
BackgroundMolecular genetics of implantation in the mouse
Rinkenberger, J. L., Cross, J. C., & Werb, Z. (1997) · Developmental Genetics · doi:10.1002/(sici)1520-6408(1997)21:1<6::aid-dvg2>3.0.co;2-b · Cited by 149
Adams, C. M., Mitra, R., Xiao, Y., Michener, P., Palazzo, J., Chao, A., Gour, J., Cassel, J., Salvino, J. M., & Eischen, C. M. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1131 · Cited by 117
Keeping an old friend under control: regulation of p53 stability
Kubbutat, M. H. G., & Vousden, K. H. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01260-x · Cited by 149
Proteolytic Cleavage of the mdm2 Oncoprotein during Apoptosis
Chen, L., Marechal, V., Moreau, J., Levine, A. J., & Chen, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22966 · Cited by 121
Targeting the Prion-like Aggregation of Mutant p53 to Combat Cancer
Silva, J. L., Cino, E. A., Soares, I. N., Ferreira, V. F., & A. P. de Oliveira, G. (2018) · Accounts of Chemical Research · doi:10.1021/acs.accounts.7b00473 · Cited by 121
P53 Regulates Myogenesis by Triggering the Differentiation Activity of Prb
Porrello, A., Cerone, M. A., Coen, S., Gurtner, A., Fontemaggi, G., Cimino, L., Piaggio, G., Sacchi, A., & Soddu, S. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.6.1295 · Cited by 121
“Montes de Oca Luna, R., D.S. Wagner, and G. Lozano.”
Godley, L. A., Kopp, J. B., Eckhaus, M., Paglino, J. J., Owens, J., & Varmus, H. E. (1996) · Genes & Development · doi:10.1101/gad.10.7.836 · Cited by 122
Chapter 1 Genetic Models of Cancer in Zebrafish
Amatruda, J. F., & Patton, E. E. (2008) · International review of cytology · doi:10.1016/s1937-6448(08)01201-x · Cited by 127
Increased apoptosis induction by 121F mutant p53
Saller, E., Tom, E., Brunori, M., Otter, M., Estreicher, A., Mack, D. H., & Iggo, R. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4424 · Cited by 130
Regulation of p53 stability and function by the deubiquitinating enzyme USP42
Hock, A. K., Vigneron, A. M., Carter, S. A., Ludwig, R. L., & Vousden, K. H. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.419 · Cited by 132
“The importance of MDM2-mediated ubiquitination of p53 has been clearly demonstrated in mouse models, where the embryonic lethality resulting from either loss of MDM2 expression, or knockin of a catalytically inactive MDM2, is completely rescued by a simultaneous deletion of p53 (Jones et al, 1995; Montes de Oca Luna e…”
Backgroundp53: emerging roles in stem cells, development and beyond
Jain, A. K., & Barton, M. C. (2018) · Development · doi:10.1242/dev.158360 · Cited by 119
“…of unchecked p53 activity during embryonic differentiation, and support for tight regulation of p53 during development, were illustrated by the early embryonic lethality of Mdm2−/− mice at implantation, a phenotype that is rescued by deletion of Trp53 (de Oca Luna et al., 1995; Jones et al., 1995).”
BackgroundUbiquitin-dependent Degradation of p73 Is Inhibited by PML
Bernassola, F., Salomoni, P., Oberst, A., Di Como, C. J., Pagano, M., Melino, G., & Pandolfi, P. P. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031943 · Cited by 119
“Although MDM2 has a critical function in the negative regulation of p53 activity in vivo (50), it does not lead to p73 degradation (12), but rather to its stabilization (51).”
BackgroundNovel targeted therapeutics: inhibitors of MDM2, ALK and PARP
Yuan, Y., Liao, Y.-M., Hsueh, C.-T., & Mirshahidi, H. (2011) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-4-16 · Cited by 131
UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53
Wu, H., Pomeroy, S. L., Ferreira, M., Teider, N., Mariani, J., Nakayama, K. I., Hatakeyama, S., Tron, V. A., Saltibus, L. F., Spyracopoulos, L., et al. (2011) · Nature Medicine · doi:10.1038/nm.2283 · Cited by 120
Haploinsufficiency of Mdm2 and Mdm4 in Tumorigenesis and Development
Terzian, T., Wang, Y., Van Pelt, C. S., Box, N. F., Travis, E. L., & Lozano, G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00555-06 · Cited by 116
“clonal antibody against Mdm2 (20) (1:500 dilution), a mouse monoclonal anti-”
BackgroundInfluentialSelf-citationQuantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation
Wang, Y. V., Wade, M., Wong, E., Li, Y.-C., Rodewald, L. W., & Wahl, G. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701497104 · Cited by 116
The p53 family in nervous system development and disease
Jacobs, W. B., Kaplan, D. R., & Miller, F. D. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03980.x · Cited by 133
“The detrimental nature of uncontrolled p53 signaling is exemplified by the embryonic lethality of the Mdm2–/– mutant mouse, and the subsequent rescue of this phenotype by the concomitant deletion of p53 (Jones et al. 1995; Montes de Oca Luna et al. 1995).”
BackgroundMdmX Protein Is Essential for Mdm2 Protein-mediated p53 Polyubiquitination
Wang, X., Wang, J., & Jiang, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213868 · Cited by 115
p53-A natural cancer killer: Structural insights and therapeutic concepts
Römer, L., Klein, C., Dehner, A., Kessler, H., & Buchner, J. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600611 · Cited by 93
Rallapalli, R., Strachan, G., Cho, B., Mercer, W. E., & Hall, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8299 · Cited by 114
14‐3‐3γ binds to MDMX that is phosphorylated by UV‐activated Chk1, resulting in p53 activation
Jin, Y., Dai, M., Lu, S. Z., Xu, Y., Luo, Z., Zhao, Y., & Lu, H. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601010 · Cited by 131
Regulation of p53 Nuclear Export through Sequential Changes in Conformation and Ubiquitination
Nie, L., Sasaki, M., & Maki, C. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610515200 · Cited by 113
p53, p63 and p73 – solos, alliances and feuds among family members
Moll, U. M., Erster, S. H., & Zaika, A. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00036-1 · Cited by 136
Freedman, D. A., & Levine, A. J. (1999) · PubMed · Cited by 140
Critical Role for a Central Part of Mdm2 in the Ubiquitylation of p53
Meulmeester, E., Frenk, R., Stad, R., de Graaf, P., Marine, J.-C., Vousden, K. H., & Jochemsen, A. G. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.14.4929-4938.2003 · Cited by 113
“Mdm2 is also a transcriptional target of p53 (21, 27), and so p53 and Mdm2 form a tight autoregulatory feedback loop, the importance of which has been genetically demonstrated by the ability of p53-null mice to rescue the embryonic lethality of mdm2-null mice (16, 25).”
Backgroundp53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
Wasylyk, C., Salvi, R., Argentini, M., Dureuil, C., Delumeau, I., Abecassis, J., Debüssche, L., & Wasylyk, B. (1999) · Oncogene · doi:10.1038/sj.onc.1202528 · Cited by 124
“During embryonic development, inactivation of the mdm2 gene results in a lethality that can be rescued by inactivation of the p53 gene (Montes de Oca Luna et al., 1995; Jones et al., 1995).”
BackgroundMdm2 and MdmX partner to regulate p53
Wang, X., & Jiang, X. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.049 · Cited by 111
“5) [24,27,85], while knockout of MdmX or knock-in of an MdmX RING mutant kills the embryos at day-9.”
BackgroundQuerido, E., Morisson, M. R., Chu-Pham-Dang, H., Thirlwell, S. W.-L., Boivin, D., & Branton, P. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.699-709.2001 · Cited by 111
Wienken, M., Dickmanns, A., Nemajerová, A., Kramer, D., Najafova, Z., Weiss, M., Karpiuk, O., Kassem, M. S., Zhang, Y., Lozano, G., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.12.008 · Cited by 125
“A mutation of the RING finger domain in Mdm2 (Itahana et al., 2007), compared to a complete deletion of Mdm2 (Montes de Oca Luna et al., 1995) affected these expression patterns in a similar way (Figures 1B and 1C; Table S2; p53 / Mdm2C462A/C462A; abbreviated p53 / Mdm2CA/CA from here on).”
BackgroundSelf-citationP53 activity is essential for normal development in Xenopus
Wallingford, J. B., Seufert, D. W., Virta, V. C., & Vize, P. D. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00333-2 · Cited by 118
“However, p53 is expressed during early murine development in a pattern consistent with a role in differentiation [12–15], and the precise regulation of expression appears to be essential for normal development [16,17].”
Generating chromosome instability through the simultaneous deletion of Mad2 and p53
Burds, A. A., Lutum, A. S., & Sorger, P. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505053102 · Cited by 109
Zhang, Q., Zeng, S. X., Zhang, Y., Zhang, Y., Ding, D., Ye, Q., Meroueh, S. O., & Lu, H. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100211 · Cited by 109
“This feedback regulation as firmly established in mouse models (Jones et al, 1995; Montes de Oca Luna et al, 1995) is subjected to tight regulation (Wade et al, 2010; Zhang & Lu, 2009).”
Anti‐apoptotic activity of low levels of wild‐type p53.
Lassus, P., Ferlin, M., Piette, J., & Hibner, U. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00834.x · Cited by 117
Aberrant hnRNP K expression: All roads lead to cancer
Gallardo, M., Aitken, M. J. L., Zhang, X., Hu, P. C., Bueso-Ramos, C., & Post, S. M. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1164372 · Cited by 123
“e; an inability to negatively regulate p53dependent apoptosis in utero).(44) However, when we generated HnrnpkC/¡;Trp53C/¡ mice and then performed sibling matings,”
BackgroundZhao, R., Yeung, S.-C. J., Chen, J., Iwakuma, T., Su, C.-H., Chen, B., Qu, C., Zhang, F., Chen, Y.-T., Lin, Y.-L., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44111 · Cited by 107
Self-citationZhang, L., & Hill, R. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3038 · Cited by 107
The bZIP transcription factor LCR-F1 is essential for mesoderm formation in mouse development.
Farmer, S. C., Sun, C. W., Winnier, G. E., Hogan, B. L., & Townes, T. M. (1997) · Genes & Development · doi:10.1101/gad.11.6.786 · Cited by 107
Gannon, H. S., Woda, B. A., & Jones, S. N. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.011 · Cited by 105
“Mdm2 / mice die at E5–E6 during development due to aberrant p53-mediated apoptosis (Jones et al., 1995; Montes de Oca Luna et al., 1995), whereas Mdm2 overexpression in mice inhibits p53 tumor suppression, resulting in the formation of lymphomas, soft tissue sarcomas, and osteosarcomas (Jones et…”
Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities
Landré, V., Rotblat, B., Melino, S., Bernassola, F., & Melino, G. (2014) · Oncotarget · doi:10.18632/oncotarget.2431 · Cited by 104
Li, M., Gou, H., Tripathi, B. K., Huang, J. L., Jiang, S., Dubois, W., Waybright, T., Lei, M., Shi, J., Zhou, M., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.04.002 · Cited by 106
“The fact that Mdm2 and Mdm4 knockout embryos survive beyond the blastocyst stage suggests that other factors prevent p53 activation in mESCs (Jones et al., 1995;Montes deOca Luna et al., 1995; Parant et al., 2001).”
MdmX Is a RING Finger Ubiquitin Ligase Capable of Synergistically Enhancing Mdm2 Ubiquitination
Badciong, J. C., & Haas, A. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208593200 · Cited by 106
Noon, A. P., Vlatković, N., Polański, R., Maguire, M., Shawki, H., Parsons, K., & Boyd, M. T. (2010) · Cancer · doi:10.1002/cncr.24841 · Cited by 106
High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension
Mason, N. A., Springall, D. R., Burke, M., Pollock, J., Mikhail, G., Yacoub, M. H., & Polak, J. M. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199807)185:3<313::aid-path93>3.0.co;2-8 · Cited by 146
Wang, H., Nan, L., Yu, D. S., Agrawal, S., & Zhang, R. (2001) · PubMed · Cited by 123
Double indemnity: p53, BRCA and cancer
Brugarolas, J., & Jacks, T. (1997) · Nature Medicine · doi:10.1038/nm0797-721 · Cited by 124
Shi, H., Tan, S.-J., Zhong, H., Hu, W., Levine, A. J., Xiao, C.-J., Peng, Y., Qi, X.-B., Shou, W., Run-lin, Z., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.03.009 · Cited by 114
“The subsequent selection of this allele would ensure that p53 levels were kept low in those populations where UV exposure would pose no risk to the health and survival and might also provide a selective advantage to these populations when adapting to new environments, because high p53 activity is associated with death…”
BackgroundRegulation of p53 - insights into a complex process
Boehme, K. A., & Blattner, C. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409230903401507 · Cited by 105
“Only when p53 was deleted as well did the animals develop normally (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
BackgroundChandler, D. S., Singh, R. K., Caldwell, L. C., Bitler, J. L., & Lozano, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4271 · Cited by 105
“The importance of the role of mdm2 in the regulation of p53 activity and stability is underscored by knockout mouse experiments, in which the early lethality of the mdm2-null embryos is rescued in mice that are also p53 null (8, 9).”
BackgroundSelf-citationCanman, C. E., & Kastan, M. B. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61068-6 · Cited by 115
TUMOR SUPPRESSOR GENE MUTATIONS IN MICE
Jacks, T. (1996) · Annual Review of Genetics · doi:10.1146/annurev.genet.30.1.603 · Cited by 105
Restoration of p53 to limit tumor growth
Wang, W., & El-Deiry, W. S. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f31d6f · Cited by 104
Mulay, S. R., Thomasová, D., Ryu, M., & Anders, H. (2012) · Kidney International · doi:10.1038/ki.2011.482 · Cited by 114
“We used p53-deficient and p53/MDM2 double-deficient mouse embryonic fibroblasts (MEFs) as a reliable and validated experimental system to identify p53-independent effects of MDM2.(30) Because postischemic renal inflammation is largely mediated via MyD88 and TLR4,(4) we used the TLR4/MyD88 agonist lipopolysaccharide (L…”
MethodInfluentialEndogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo
Phesse, T. J., Myant, K. B., Cole, A. M., Ridgway, R. A., Pearson, H., Muncan, V, van den Brink, G. R., Vousden, K. H., Sears, R., Vassilev, L. T., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.15 · Cited by 103
“Loss of Mdm2 in vivo leads to embryonic death due to the activation of high levels of p53, which can be rescued by co-deletion of p53.(31,32) First we examined the levels of Mdm2 following c-Myc deletion by immunohistochemistry and immunoblotting.”
BackgroundKhurana, A., & Shafer, D. A. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s172315 · Cited by 102
Tang, S. J., Hoodless, P. A., Lu, Z., Breitman, M. L., McInnes, R. R., Wrana, J. L., & Buchwald, M. (1998) · Development · doi:10.1242/dev.125.10.1877 · Cited by 103
Cellular lifespan and senescence signaling in embryonic stem cells
Miura, T., Mattson, M. P., & Rao, M. S. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00134.x · Cited by 102
“Although p53-null mice are viable (Donehower et al., 1992; Jacks et al., 1994), mice lacking mdm2, which is a negative regulator of p53, die at an early embryo stage (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
BackgroundTumour suppressors: A developing role for p53?
Hall, P. A., & Lane, D. P. (1997) · Current Biology · doi:10.1016/s0960-9822(97)70074-5 · Cited by 101
Analysis of the degradation function of Mdm2.
Kubbutat, M. H. G., Ludwig, R., Levine, A. J., & Vousden, K. H. (1999) · PubMed · Cited by 121
The Role of the Apoptotic Machinery in Tumor Suppression
Delbridge, A. R. D., Valente, L. J., & Strasser, A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008789 · Cited by 102
Pluquet, O., Qu, L.-K., Baltzis, D., & Koromilas, A. E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9392-9405.2005 · Cited by 101
“The importance of this autoregulatory loop was demonstrated when the lethality of mdm2null mice was rescued by the deletion of the p53 gene (22, 41 ).”
BackgroundJain, A. K., Allton, K., Duncan, A. D., & Barton, M. C. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01705-12 · Cited by 101
“However, a striking observation is that p53 degradation occurs even in Mdm2-deficient mouse tissues during cellular recovery after DNA damage (14).”
BackgroundNucleostemin Delays Cellular Senescence and Negatively Regulates TRF1 Protein Stability
Zhu, Q., Yasumoto, H., & Tsai, R. Y. L. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00724-06 · Cited by 109
“These data place NS among a few genes, including TRF1 (11) and MDM2 (17), whose deletions were shown to cause embryonic lethality around implantation and provide functional evidence connecting a stem cell pathway with cellular aging.”
Autophagy promotes mammalian survival by suppressing oxidative stress and p53
Yang, Y., Karsli-Uzunbas, G., Poillet-Perez, L., Sawant, A., Hu, Z. S., Zhao, Y., Moore, D., Hu, W., & White, E. (2020) · Genes & Development · doi:10.1101/gad.335570.119 · Cited by 100
“Mol Biol Cell 15: 1101–1111. doi:10 .1091/mbc.e03-09-0704 Montes de Oca Luna R, Wagner DS, Lozano G. 1995.”
BackgroundMdmX is a substrate for the deubiquitinating enzyme USP2a
Allende-Vega, N., Sparks, A., Lane, D. P., & Saville, M. K. (2010) · Oncogene · doi:10.1038/onc.2009.330 · Cited by 100
Discovery of Mdm2-MdmX E3 Ligase Inhibitors Using a Cell-Based Ubiquitination Assay
Herman, A. G., Hayano, M., Poyurovsky, M. V., Shimada, K., Skouta, R., Prives, C., & Stockwell, B. R. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0104 · Cited by 100
Targeting of C-Terminal Binding Protein (CtBP) by ARF Results in p53-Independent Apoptosis
Paliwal, S., Pande, S., Kovi, R. C., Sharpless, N. E., Bardeesy, N. M., & Grossman, S. R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2360-2372.2006 · Cited by 117
“In comparison, mice with loss of p53 and Mdm2 but retention of Arf display mainly mesenchymal tumors, as do p53 knockout mice (19, 30, 48).”
BackgroundMSL2 Promotes Mdm2-independent Cytoplasmic Localization of p53
Kruse, J.-P., & Gu, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805658200 · Cited by 100
Duong, V., Boulle, N., Daujat, S., Chauvet, J., Bonnet, S., Neel, H., & Cavaillès, V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0967 · Cited by 112
“To evaluate the role of Mdm2 and p53 in a liganddependent down-regulation of ERa, we first used the MEFdKO model (32).”
BackgroundMethodRegulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase
Xu, C., Fan, C., & Wang, X. (2014) · Oncogene · doi:10.1038/onc.2013.557 · Cited by 107
Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer
Patel, S., & Player, M. R. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802493366 · Cited by 99
“It was demonstrated that mice lacking the MDM2 gene are embryonic-lethal (die early in development), but this lethality is fully rescued by deletion of p53, suggesting that the activity of p53 is regulated by MDM2 [23,24] .”
BackgroundSalomon, R., & Díaz‐Cano, S. J. (1995) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199512000-00002 · Cited by 106
Havel, L., & Durzan, D. J. (1996) · Botanica Acta · doi:10.1111/j.1438-8677.1996.tb00573.x · Cited by 99
Differential Regulation of Cardiomyocyte Survival and Hypertrophy by MDM2, an E3 Ubiquitin Ligase
Tóth, A., Nickson, P., Qin, L. L., & Erhardt, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509630200 · Cited by 104
Daujat, S., NEEL, H., & PIETTE, J. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02369-1 · Cited by 116
An Alternative Splice Form of Mdm2 Induces p53-independent Cell Growth and Tumorigenesis
Steinman, H. A., Burstein, E., Lengner, C., Gosselin, J., Pihan, G., Duckett, C. S., & Jones, S. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305966200 · Cited by 96
Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation
Jiang, M., Pabla, N., Murphy, R. F., Yang, T., Yin, X.-M., Degenhardt, K., White, E., & Dong, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606928200 · Cited by 97
The potential roles for embryotrophic ligands in preimplantation embryo development
O’Neill, C. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn002 · Cited by 101
Centanin, L., Ratcliffe, P. J., & Wappner, P. (2005) · EMBO reports · doi:10.1038/sj.embor.7400528 · Cited by 97
“…restores the ability of the organism to develop: (i) Mdm2 knockout mice fail to develop beyond embryonic day 6.5, but concomitant genetic ablation of its dedicated target molecule, p53, allows the development of normal and fertile adult mice (Jones et al, 1995; Montes de Oca Luna et al, 1995).”
BackgroundInfluentialImproving cancer therapy by non-genotoxic activation of p53
Laín, S., & Lane, D. P. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00063-7 · Cited by 106
Melatonin down‐regulates MDM 2 gene expression and enhances p53 acetylation in MCF‐7 cells
Proietti, S., Cucina, A., Dobrowolny, G., D'Anselmi, F., Dinicola, S., Masiello, M. G., Pasqualato, A., Palombo, A., Morini, V., Reiter, R. J., et al. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12150 · Cited by 96
“The importance of MDM2 in controlling p53 functions is well documented by studies performed on MDM2 knockdown animals, in which the loss of MDM2 leads to uncontrolled p53 activity and subsequent embryonic lethality [25].”
BackgroundCell fate regulation governed by p53: Friends or reversible foes in cancer therapy
Song, B., Yang, P., & Zhang, S. (2024) · 癌症:英文版 · doi:10.1002/cac2.12520 · Cited by 107
Nuclear degradation of p53 occurs during down‐regulation of the p53 response after DNA damage
Shirangi, T. R., Zaika, A., & Moll, U. M. (2002) · The FASEB Journal · doi:10.1096/fj.01-0617fje · Cited by 96
“The significance of this autoregulatory feedback loop becomes dramatically apparent in MDM2-deficient mice, which die early in embryogenesis due to unchecked p53 activity (7, 8).”
BackgroundUnleashing the power of p53: lessons from mice and men: Figure 1.
Poyurovsky, M. V., & Prives, C. (2006) · Genes & Development · doi:10.1101/gad.1397506 · Cited by 96
“…maintaining the p53–Mdm2–MdmX circuitry, perhaps the most compelling being the fact that it is not possible to produce viable Mdm2- or Mdmx-null mice unless either are generated in a p53-null background (Jones et al. 1995; Montes de Oca Luna et al. 1995; Parant et al. 2001; Migliorini et al. 2002).”
BackgroundMet acts on Mdm2 via mTOR to signal cell survival during development
Moumen, A., Patané, S., Porras, A., Dono, R., & Maina, F. (2007) · Development · doi:10.1242/dev.02820 · Cited by 95
p53-Independent Effects of Mdm2
Bohlman, S., & Manfredi, J. J. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_13 · Cited by 103
Jab1 Induces the Cytoplasmic Localization and Degradation of p53 in Coordination with Hdm2
Oh, W., Lee, E., Sung, Y. H., Yang, M.-R., Ghim, J., Lee, H., & Song, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601857200 · Cited by 102
mTORC1 and p53: Clash of the gods?
Hasty, P., Sharp, Z. D., Curiel, T. J., & Campisi, J. (2013) · Cell Cycle · doi:10.4161/cc.22912 · Cited by 94
“In mice, for example, MDM2 deletion is early embryonic lethal, and lethality is rescued by p53 deletion.(18,19) In addition to ubiquitination, other post-translational p53 modifications include phosphorylation and acetylation, neddylation, sumoylation and methylation, all of which are essential for modulating p53 acti…”
BackgroundThe p53 target Wig-1 regulates p53 mRNA stability through an AU-rich element
Vilborg, A., Glahder, J. A., Wilhelm, M., Bersani, C., Corcoran, M., Mahmoudi, S., Rosenstierne, M. W., Grandér, D., Farnebo, M., Norrild, B., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900862106 · Cited by 94
“Too much or uncontrolled p53 causes cell death, as demonstrated by the fact that mice null for the important negative p53 regulator mouse double minute 2 (Mdm2) die early during embryogenesis because of excessive p53-dependent apoptosis (4).”
BackgroundRoles of ubiquitin signaling in transcription regulation
Hammond-Martel, I., Yu, H., & Affar, E. B. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.10.009 · Cited by 110
Mdm2 in the Response to Radiation
Perry, M. E. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.9.2.1 · Cited by 94
Wadgaonkar, R., & Collins, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13760 · Cited by 94
A Novel Cellular Protein (MTBP) Binds to MDM2 and Induces a G1 Arrest That Is Suppressed by MDM2
Boyd, M. T., Vlatkovic, N., & Haines, D. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004252200 · Cited by 94
mdm2: a bridge over the two tumour suppressors, p53 and Rb
Yap, D., Hsieh, J.-K., Chan, F., & Lü, X. (1999) · Oncogene · doi:10.1038/sj.onc.1202954 · Cited by 105
“…ability of p53 The ability of mdm2 to inhibit the activity of p53 is arguably the most important role of mdm2 as the knock-out mice studies showed that mdm2 knock-out mice are embryonic lethal but p53 and mdm2 double knock-out mice develop to term (de Oca Luna et al., 1995; Jones et al., 1995).”
BackgroundLozano, G. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001115 · Cited by 94
“The best examples of the detrimental effects of high p53 activity on development are the Mdm2-null and Mdm4-null mice (Jones et al. 1995; Montes de Oca Luna et al. 1995; Parant et al. 2001; Migliorini et al. 2002).”
BackgroundSelf-citationP14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2
Xirodimas, D. P., Chisholm, J., Desterro, J. M. S., Lane, D. P., & Hay, R. T. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03310-0 · Cited by 94
Metadata
- Authors
- de Oca Luna, R. M., Wagner, D. S., & Lozano, G.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Venue
- Nature
- Published
- 1995-11
- Volume
- 378
- Issue
- 6553
- Pages
- 203-206
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1969044026
- Semantic Scholar
- e682601f6b2b8de8fa63cc39518a1461943483bc
- Cited by
- 1,420
- References
- 29
- Citations by year
- 2026: 10 · 2025: 24 · 2024: 31 · 2023: 30 · 2022: 31 · 2021: 32 · 2020: 49 · 2019: 29 · 2018: 32 · 2017: 49 · 2016: 63 · 2015: 44 · 2014: 67 · 2013: 37 · 2012: 63
- FWCI
- 15.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, MDM2, embryonic lethality, p53-MDM2 interaction, tumor suppressor, sarcoma, homologous recombination, DNA repair
- MeSH terms
- Animals, Base Sequence, Cell Line, Crosses, Genetic, Female, Genes, Lethal, Heterozygote, Homozygote, Male, Mice, Inbred C57BL, Molecular Sequence Data, Nuclear Proteins, Proto-Oncogene Proteins, Tumor Suppressor Protein p53, Gene Deletion, DNA Primers, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.